What does the pharmacological future of treating chronic hepatitis C look like?

Abstract excerpt

Development of direct acting antivirals has revolutionized the standard of care for the treatment of hepatitis C virus. New interferon-free regimens provide sustained virologic response rates of >90% in many genotype 1 patients with only 12 weeks of oral therapy. This review will provide a brief overview of current standards of care with a summary of the evidence supporting the recommended combinations of direct...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Administration, Oral
• Share to Antiviral Agents
• Share to Drug Therapy, Combination